TY - JOUR AU - Planchard, D. AU - Popat, S. AU - Kerr, K. AU - Novello, S. AU - Smit, E. F. AU - Faivre-Finn, C. PY - 2018 DA - 2018// TI - Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 29 UR - https://doi.org/10.1093/annonc/mdy275 DO - 10.1093/annonc/mdy275 ID - Planchard2018 ER - TY - JOUR AU - Gan, G. N. AU - Weickhardt, A. J. AU - Scheier, B. AU - Doebele, R. C. AU - Gaspar, L. E. AU - Kavanagh, B. D. PY - 2014 DA - 2014// TI - Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib JO - Int J Radiat Oncol Biol Phys VL - 88 UR - https://doi.org/10.1016/j.ijrobp.2013.11.010 DO - 10.1016/j.ijrobp.2013.11.010 ID - Gan2014 ER - TY - JOUR AU - Merino Lara, T. AU - Helou, J. AU - Poon, I. AU - Sahgal, A. AU - Chung, H. T. AU - Chu, W. PY - 2018 DA - 2018// TI - Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy? JO - Lung Cancer VL - 124 UR - https://doi.org/10.1016/j.lungcan.2018.08.005 DO - 10.1016/j.lungcan.2018.08.005 ID - Merino Lara2018 ER - TY - JOUR AU - Schmid, S. AU - Klingbiel, D. AU - Aeppli, S. AU - Britschgi, C. AU - Gautschi, O. AU - Pless, M. PY - 2019 DA - 2019// TI - Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort study JO - Lung Cancer VL - 130 UR - https://doi.org/10.1016/j.lungcan.2019.02.020 DO - 10.1016/j.lungcan.2019.02.020 ID - Schmid2019 ER - TY - JOUR AU - Weickhardt, A. J. AU - Scheier, B. AU - Burke, J. M. AU - Gan, G. AU - Lu, X. AU - Bunn, P. A. PY - 2012 DA - 2012// TI - Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer JO - J Thorac Oncol VL - 7 UR - https://doi.org/10.1097/JTO.0b013e3182745948 DO - 10.1097/JTO.0b013e3182745948 ID - Weickhardt2012 ER - TY - JOUR AU - Yu, H. A. AU - Sima, C. S. AU - Huang, J. AU - Solomon, S. B. AU - Rimner, A. AU - Paik, P. PY - 2013 DA - 2013// TI - Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors JO - J Thorac Oncol VL - 8 UR - https://doi.org/10.1097/JTO.0b013e31827e1f83 DO - 10.1097/JTO.0b013e31827e1f83 ID - Yu2013 ER - TY - JOUR AU - Gomez, D. R. AU - Tang, C. AU - Zhang, J. AU - Blumenschein, G. R. AU - Hernandez, M. AU - Lee, J. J. PY - 2019 DA - 2019// TI - Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study JO - J Clin Oncol VL - 37 UR - https://doi.org/10.1200/JCO.19.00201 DO - 10.1200/JCO.19.00201 ID - Gomez2019 ER - TY - JOUR AU - Iyengar, P. AU - Wardak, Z. AU - Gerber, D. E. AU - Tumati, V. AU - Ahn, C. AU - Hughes, R. S. PY - 2018 DA - 2018// TI - Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2017.3501 DO - 10.1001/jamaoncol.2017.3501 ID - Iyengar2018 ER - TY - STD TI - Palma DO, R.; Harrow, S.; Gaede, S.; Louie, A.; Haasbeek, C. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet Oncol. 2019;s0140–6736:32487–5. ID - ref9 ER - TY - JOUR AU - Pitroda, S. P. AU - Khodarev, N. N. AU - Huang, L. AU - Uppal, A. AU - Wightman, S. C. AU - Ganai, S. PY - 2018 DA - 2018// TI - Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis JO - Nat Commun VL - 9 UR - https://doi.org/10.1038/s41467-018-04278-6 DO - 10.1038/s41467-018-04278-6 ID - Pitroda2018 ER - TY - JOUR AU - Ashworth, A. AU - Rodrigues, G. AU - Boldt, G. AU - Palma, D. PY - 2013 DA - 2013// TI - Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature JO - Lung Cancer VL - 82 UR - https://doi.org/10.1016/j.lungcan.2013.07.026 DO - 10.1016/j.lungcan.2013.07.026 ID - Ashworth2013 ER - TY - JOUR AU - Guckenberger, M. AU - Lievens, Y. AU - Bouma, A. B. AU - Collette, L. AU - Dekker, A. AU - deSouza, N. M. PY - 2020 DA - 2020// TI - Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation JO - Lancet Oncol VL - 21 UR - https://doi.org/10.1016/S1470-2045(19)30718-1 DO - 10.1016/S1470-2045(19)30718-1 ID - Guckenberger2020 ER - TY - JOUR AU - Lovly, C. M. AU - Iyengar, P. AU - Gainor, J. F. PY - 2017 DA - 2017// TI - Managing resistance to EFGR- and ALK-targeted therapies JO - Am Soc Clin Oncol Educ Book VL - 37 UR - https://doi.org/10.14694/EDBK_176251 DO - 10.14694/EDBK_176251 ID - Lovly2017 ER - TY - JOUR AU - Leeuwen, C. M. AU - Oei, A. L. AU - Crezee, J. AU - Bel, A. AU - Franken, N. A. P. AU - Stalpers, L. J. A. PY - 2018 DA - 2018// TI - The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies JO - Radiat Oncol VL - 13 UR - https://doi.org/10.1186/s13014-018-1040-z DO - 10.1186/s13014-018-1040-z ID - Leeuwen2018 ER - TY - JOUR AU - Lodeweges, J. E. AU - Klinkenberg, T. J. AU - Ubbels, J. F. AU - Groen, H. J. M. AU - Langendijk, J. A. AU - Widder, J. PY - 2017 DA - 2017// TI - Long-term outcome of surgery or stereotactic radiotherapy for lung oligometastases JO - J Thorac Oncol VL - 12 UR - https://doi.org/10.1016/j.jtho.2017.05.015 DO - 10.1016/j.jtho.2017.05.015 ID - Lodeweges2017 ER - TY - JOUR AU - Russo, A. AU - Franchina, T. AU - Ricciardi, G. R. R. AU - Smiroldo, V. AU - Picciotto, M. AU - Zanghi, M. PY - 2017 DA - 2017// TI - Third generation EGFR TKIs in EGFR-mutated NSCLC: where are we now and where are we going JO - Crit Rev Oncol Hematol VL - 117 UR - https://doi.org/10.1016/j.critrevonc.2017.07.003 DO - 10.1016/j.critrevonc.2017.07.003 ID - Russo2017 ER - TY - JOUR AU - Yang, J. C. AU - Wu, Y. L. AU - Schuler, M. AU - Sebastian, M. AU - Popat, S. AU - Yamamoto, N. PY - 2015 DA - 2015// TI - Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(14)71173-8 DO - 10.1016/S1470-2045(14)71173-8 ID - Yang2015 ER - TY - JOUR AU - Al-Halabi, H. AU - Sayegh, K. AU - Digamurthy, S. R. AU - Niemierko, A. AU - Piotrowska, Z. AU - Willers, H. PY - 2015 DA - 2015// TI - Pattern of failure analysis in metastatic EGFR-mutant lung cancer treated with tyrosine kinase inhibitors to identify candidates for consolidation stereotactic body radiation therapy JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000648 DO - 10.1097/JTO.0000000000000648 ID - Al-Halabi2015 ER - TY - JOUR AU - Campo, M. AU - Al-Halabi, H. AU - Khandekar, M. AU - Shaw, A. T. AU - Sequist, L. V. AU - Willers, H. PY - 2016 DA - 2016// TI - Integration of stereotactic body radiation therapy with tyrosine kinase inhibitors in stage IV oncogene-driven lung cancer JO - Oncologist VL - 21 UR - https://doi.org/10.1634/theoncologist.2015-0508 DO - 10.1634/theoncologist.2015-0508 ID - Campo2016 ER - TY - JOUR AU - Jamal-Hanjani, M. AU - Wilson, G. A. AU - McGranahan, N. AU - Birkbak, N. J. AU - Watkins, T. B. K. AU - Veeriah, S. PY - 2017 DA - 2017// TI - Tracking the evolution of non-small-cell lung cancer JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1616288 DO - 10.1056/NEJMoa1616288 ID - Jamal-Hanjani2017 ER - TY - JOUR AU - Iyengar, P. AU - Kavanagh, B. D. AU - Wardak, Z. AU - Smith, I. AU - Ahn, C. AU - Gerber, D. E. PY - 2014 DA - 2014// TI - Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2014.56.7412 DO - 10.1200/JCO.2014.56.7412 ID - Iyengar2014 ER - TY - JOUR AU - Arvold, N. D. AU - Lee, E. Q. AU - Mehta, M. P. AU - Margolin, K. AU - Alexander, B. M. AU - Lin, N. U. PY - 2016 DA - 2016// TI - Updates in the management of brain metastases JO - Neuro Oncol VL - 18 UR - https://doi.org/10.1093/neuonc/now127 DO - 10.1093/neuonc/now127 ID - Arvold2016 ER - TY - JOUR AU - Habets, E. J. AU - Dirven, L. AU - Wiggenraad, R. G. AU - Verbeek-de Kanter, A. AU - Lycklama, A. N. G. J. AU - Zwinkels, H. PY - 2016 DA - 2016// TI - Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study JO - Neuro Oncol VL - 18 UR - https://doi.org/10.1093/neuonc/nov186 DO - 10.1093/neuonc/nov186 ID - Habets2016 ER - TY - JOUR AU - Magnuson, W. J. AU - Lester-Coll, N. H. AU - Wu, A. J. AU - Yang, T. J. AU - Lockney, N. A. AU - Gerber, N. K. PY - 2017 DA - 2017// TI - Management of brain metastases in tyrosine kinase inhibitor-naive epidermal growth factor receptor-mutant non-small-cell lung cancer: a retrospective multi-institutional analysis JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2016.69.7144 DO - 10.1200/JCO.2016.69.7144 ID - Magnuson2017 ER - TY - JOUR AU - Ni, J. AU - Li, G. AU - Yang, X. AU - Chu, L. AU - Wang, J. AU - Li, Y. PY - 2019 DA - 2019// TI - Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses JO - Radiat Oncol VL - 14 UR - https://doi.org/10.1186/s13014-019-1240-1 DO - 10.1186/s13014-019-1240-1 ID - Ni2019 ER - TY - JOUR AU - Dunne, E. M. AU - Fraser, I. M. AU - Liu, M. PY - 2018 DA - 2018// TI - Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions JO - Ann Transl Med VL - 6 UR - https://doi.org/10.21037/atm.2018.06.40 DO - 10.21037/atm.2018.06.40 ID - Dunne2018 ER - TY - STD TI - Seiwert TY, Kiess AP. J Clin Oncol. 2020 Sept 28: Online ahead of print. ID - ref27 ER - TY - JOUR AU - Siva, S. AU - MacManus, M. P. AU - Martin, R. F. AU - Martin, O. A. PY - 2015 DA - 2015// TI - Abscopal effects of radiation therapy: a clinical review for the radiobiologist JO - Cancer Lett VL - 356 UR - https://doi.org/10.1016/j.canlet.2013.09.018 DO - 10.1016/j.canlet.2013.09.018 ID - Siva2015 ER - TY - JOUR AU - Fukushi, K. AU - Narita, T. AU - Hatakeyama, S. PY - 2017 DA - 2017// TI - Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma JO - Int J Urol VL - 24 UR - https://doi.org/10.1111/iju.13318 DO - 10.1111/iju.13318 ID - Fukushi2017 ER - TY - JOUR AU - Elamin, Y. Y. AU - Gomez, D. R. AU - Antonoff, M. B. AU - Robichaux, J. P. AU - Tran, H. AU - Shorter, M. K. PY - 2019 DA - 2019// TI - Local consolidation therapy (LCT) after first line tyrosine kinase inhibitor (TKI) for patients with EGFR mutant metastatic non-small-cell lung cancer (NSCLC) JO - Clin Lung Cancer VL - 20 UR - https://doi.org/10.1016/j.cllc.2018.09.015 DO - 10.1016/j.cllc.2018.09.015 ID - Elamin2019 ER -